| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Diagnostic and Interventional Radiology, University Hospital Essen, Essen, Germany
2 Department of Nuclear Medicine, University Hospital Essen, Essen, Germany
In combined PET/CT imaging, functional data provided by 18F-FDG increase diagnostic accuracy over conventional PET and CT in a variety of malignancies. The question to be raised is: how much is CT needed in PET/CT imaging? Discussion: In stand-alone CT imaging, contrast agents are applied to aid differentiation of anatomic structures, improve lesion localization, and support lesion characterization. Based on our experience, the most important benefit when applying CT contrast agents in PET/CT imaging relates to more precise anatomic localization of pathology by differentiation of the lesion from its surrounding structures on CT. This benefit must be considered most profound in the head and neck as well as the abdomen and pelvis, where delineation of pathology from muscles, vascular structures, or the intestine is critical. CT contrast agents can be of additional value in tumors with only mild or no increase in 18F-FDG uptake by supporting lesion detection and characterization. The complementary role of CT contrast agents and molecular contrast for PET/CT imaging is addressed in this review. The authors provide specific indications as to which contrast-enhanced CT data provide additional diagnostic value. Conclusion: Functional contrast aids lesion detection and characterization, whereas morphologic contrast improves lesion localization. CT contrast agents and PET tracers do not compete but rather are complementary in combined PET/CT imaging.
Key Words: oncology • PET/CT • 18F-FDG • contrast agents • fusion
This article has been cited by other articles:
|
|
 |
|
  W. De Wever, S. Stroobants, J. Coolen, and J. A. Verschakelen Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration Eur. Respir. J., January 1, 2009; 33(1): 201 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Townsend Dual-Modality Imaging: Combining Anatomy and Function J. Nucl. Med., June 1, 2008; 49(6): 938 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Vogt, G. Antoch, P. Veit, L. S. Freudenberg, N. Blechschmid, O. Diersch, A. Bockisch, J. Barkhausen, and H. Kuehl Morphologic and Functional Changes in Nontumorous Liver Tissue After Radiofrequency Ablation in an In Vivo Model: Comparison of 18F-FDG PET/CT, MRI, Ultrasound, and CT J. Nucl. Med., November 1, 2007; 48(11): 1836 - 1844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A C Pfannenberg, P Aschoff, K Brechtel, M Muller, M Klein, R Bares, C D Claussen, and S M Eschmann Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging Br. J. Radiol., June 1, 2007; 80(954): 437 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. De Wever, Y. Vankan, S. Stroobants, and J. Verschakelen Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer Eur. Respir. J., May 1, 2007; 29(5): 995 - 1002. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Z. Wong, E. K. Paulson, R. C. Nelson, E. F. Patz Jr., and R. E. Coleman Practical Approach to Diagnostic CT Combined with PET Am. J. Roentgenol., March 1, 2007; 188(3): 622 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Juweid, S. Stroobants, O. S. Hoekstra, F. M. Mottaghy, M. Dietlein, A. Guermazi, G. A. Wiseman, L. Kostakoglu, K. Scheidhauer, A. Buck, et al. Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma J. Clin. Oncol., February 10, 2007; 25(5): 571 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Blodgett, C. C. Meltzer, and D. W. Townsend PET/CT: Form and Function Radiology, February 1, 2007; 242(2): 360 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Czernin and H. R. Schelbert Introduction J. Nucl. Med., January 1, 2007; 48(1_suppl): 2S - 3S. [Full Text] [PDF]
|
|
|
|
|
|
H. Kuehl, P. Veit, S. J. Rosenbaum, A. Bockisch, and G. Antoch Can PET/CT Replace Separate Diagnostic CT for Cancer Imaging? Optimizing CT Protocols for Imaging Cancers of the Chest and Abdomen J. Nucl. Med., January 1, 2007; 48(1_suppl): 45S - 57S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Rodriguez-Vigil, N. Gomez-Leon, I. Pinilla, D. Hernandez-Maraver, J. Coya, L. Martin-Curto, and R. Madero PET/CT in Lymphoma: Prospective Study of Enhanced Full-Dose PET/CT Versus Unenhanced Low-Dose PET/CT J. Nucl. Med., October 1, 2006; 47(10): 1643 - 1648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Blake, A. Singh, B. N. Setty, J. Slattery, M. Kalra, M. M. Maher, D. V. Sahani, A. J. Fischman, and P. R. Mueller Pearls and Pitfalls in Interpretation of Abdominal and Pelvic PET-CT RadioGraphics, September 1, 2006; 26(5): 1335 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Brechtel, M. Klein, M. Vogel, M. Mueller, P. Aschoff, T. Beyer, S. M. Eschmann, R. Bares, C. D. Claussen, and A. C. Pfannenberg Optimized Contrast-Enhanced CT Protocols for Diagnostic Whole-Body 18F-FDG PET/CT: Technical Aspects of Single-Phase Versus Multiphase CT Imaging J. Nucl. Med., March 1, 2006; 47(3): 470 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Allen-Auerbach, K. Yeom, J. Park, M. Phelps, and J. Czernin Standard PET/CT of the Chest During Shallow Breathing Is Inadequate for Comprehensive Staging of Lung Cancer J. Nucl. Med., February 1, 2006; 47(2): 298 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Mawlawi, J. J. Erasmus, R. F. Munden, T. Pan, A. E. Knight, H. A. Macapinlac, D. A. Podoloff, and M. Chasen Quantifying the Effect of IV Contrast Media on Integrated PET/CT: Clinical Evaluation Am. J. Roentgenol., February 1, 2006; 186(2): 308 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Raanani, Y. Shasha, C. Perry, U. Metser, E. Naparstek, S. Apter, A. Nagler, A. Polliack, I. Ben-Bassat, and E. Even-Sapir Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Ann. Onc., January 1, 2006; 17(1): 117 - 122. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
